Graduate School of Frontier Sciences, The University of Tokyo Department of
Integrated Biosciences

In my Ph.D., I was dedicated to study cell cycle machineries of mouse preimplantation embryos in Reproductive Biology Laboratory, Graduate School of Agriculture, Kyoto University. This marked a decisive turning point in my carrier to live as a scientist for the rest of my life. In my postdoctoral training, switching research field from embryology to tumor biology, I worked for Dr. Junjie Chen and Dr. Fergus Couch at Mayo Clinic (Rochester, MN, USA) for four and half years to investigate molecular functions of BRCA2 gene, which is known as tumor suppressor genes in familial breast and ovarian cancers. After my postdoc, I worked for Oncology Drug Discovery Unit at Takeda Pharmaceutical Company Ltd. starting new carrier as an industry scientist. For 12 years as the industry scientist, I have experienced a series of drug discovery process from the beginning to the end: kick-off new projects, conduct preclinical studies form compound screening to clinical candidate selection, and build the translational/clinical strategies as global team members. In September 2018, I joined National Cancer Center, Kashiwa Campus, to lead basic and translational projects for development of novel cancer therapeutic drugs. I am committed to contribute to drug discovery of novel cancer therapeutics, especially Japan-oriented drug discovery in domestic and international collaborations with academia, pharmaceuticals, and biotech companies.